Tsukuba, Japan

Tetsuya Ohtaki



Average Co-Inventor Count = 4.6

ph-index = 7

Forward Citations = 159(Granted Patents)


Location History:

  • Ibaraki, JP (1999 - 2010)
  • Tsukuba, JP (1997 - 2013)

Company Filing History:


Years Active: 1997-2013

Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: Tetsuya Ohtaki: Innovator in Cancer Research and Gonadal Function

Introduction

Tetsuya Ohtaki is a prominent inventor based in Tsukuba, Japan, recognized for his significant contributions to the field of medical research, specifically focusing on cancer treatment and hormonal regulation. With a total of 21 patents to his name, Ohtaki has made notable strides in developing innovative therapeutics that target critical health issues.

Latest Patents

Ohtaki's latest patents showcase his groundbreaking work in cancer metastasis and hormonal function. One of his key inventions involves metastin derivatives, which are modified amino acids with enhanced blood stability that demonstrate a remarkable ability to inhibit cancer metastasis and growth. This patent emphasizes the therapeutic potential of these derivatives in oncology.

Additionally, Ohtaki has developed methods for inhibiting the secretion of follicle-stimulating hormone and testosterone. His research indicates that metastin and related compounds can serve as valuable agents for improving gonadal function, inducing ovulation, and treating conditions such as sterility and hormone-sensitive cancers. These inventions have broad implications for pharmaceutical screening and treatment methodologies.

Career Highlights

Ohtaki has had a distinguished career, working with esteemed organizations such as Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. His innovative approach and scientific expertise have positioned him as a key figure in the pharmaceutical industry, contributing to advancements in both drug discovery and therapeutic applications.

Collaborations

Throughout his career, Tetsuya Ohtaki has collaborated with talented scientists and researchers, including Chieko Kitada and Yasushi Masuda. These partnerships have enriched his research and amplified the impact of his innovations in the medical field.

Conclusion

Tetsuya Ohtaki's pioneering work in the development of metastin derivatives and methods for hormonal regulation exemplifies the impact of innovative research on healthcare. His patents not only advance cancer treatment but also offer solutions for hormonal disorders, demonstrating the importance of scientific innovation in improving human health. Ohtaki's contributions solidify his status as a vital inventor in the realm of medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…